Adre du Plessis (USA)View bio
Adre du Plessis is Director of the Fetal Medicine Institute at Children’s National in Washington DC. As a fetal-neonatal neurologist, his career has focused on the immature brain, understanding its normal development, as well as the causes and consequences of abnormal brain development. Embracing its clinical, research and training aspects, he has been at the forefront of developing this unique emerging discipline. He is a graduate of the University of Cape Town Medical School, and spent his formative training years at Groote Schuur, Tygerberg, and Red Cross Hospital in Cape Town, as well as at Cecilia Makiwane Hospital in the Eastern Cape. He underwent child neurology training at St. Louis Children’s and Boston Children’s Hospitals under the mentorship of Joseph J. Volpe, the ‘father’ of neonatal neurology. Dr. du Plessis became the founding director of the first-ever dedicated clinical program for neonatal (and later fetal-neonatal) neurology at Boston Children’s Hospital and Harvard’s Longwood-area medical centers. Since assuming his current position as Chief of Fetal and Transitional Medicine and Director of the Fetal Medicine Institute at Children’s National Dr. du Plessis has overseen the development of a multidisciplinary clinical, research, and training program, that has a unique focus on the developing brain. Over the past 25 years his team has developed multimodal neuromonitoring devices that allow an unprecedented depth of continuous bedside inquiry into both the systemic support systems as well as autoregulatory systems intrinsic to the brain. A major focus of this work is on the developmental effects of preterm, even late preterm, exposure to the extrauterine environment on the immature brain.
F Groenendaal (Netherlands)View bio
Floris Groenendaal finished Medical School of the Erasmus University Rotterdam in 1984.
From 1984-1986 he worked at the Institute of Physiology I (Neurophysiology) of the Erasmus University Rotterdam and defended his PhD thesis: “Perinatal hypoxia and visual functions in infants and children” in January 1988.
From 1986-1991 he was trained in pediatrics in the Sophia Children’s Hospital in Rotterdam.
His fellowship neonatology was spent at the Sophia Children’s Hospital, Rotterdam (1991), and the Wilhelmina Children’s Hospital, Utrecht (1991-1993).
In 1994 he spent his post-doc period at the Department of Physiology of the University of Pennsylvania, Philadelphia, USA. The main focus of his scientific research is:
early detection of neonatal brain injury (including MR techniques) and neuroprotection.
In 2012 He finished obtained a master degree in Clinical Epidemiology at the Julius Center of the University Medical Center Utrecht.
Since April 1993 he is consultant neonatology at the Wilhelmina Children’s Hospital/University Medical Center, Utrecht, The Netherlands.
At present he is associate professor of neonatology.
From 1984 research efforts of Floris Groenendaal were aimed at the effects of perinatal hypoxia on the central nervous system of the human neonate, as well as of animal models.
Since his employment by the Utrecht University/Wilhelmina Children’s Hospital research was part of the program Perinatal Functional Development of the Faculty of Medicine.
After returning to Utrecht his translational research focused on neuroprotective strategies after perinatal asphyxia and neonatal stroke.
Meanwhile his clinical research aimed at early diagnosis of acquired brain lesions in neonates, using cranial ultrasound, MRI and proton MRS, evoked potentials and aEEG.
Furthermore, neuroprotective strategies were examined in patients admitted to the NICU, including patients with posthemorrhagic hydrocephalus, neonatal stroke, or hypoxic-ischemic encephalopathy. In 2007/2008 he introduced therapeutic hypothermia in The Netherlands and Flanders.
Memberships of societies
active member of the European Society for Pediatric Research (ESPR, www.espr.info)
affiliate member of the Society for Pediatric Research (SPR, www.aps-spr.org)
member of the European Society for Magnetic Resonance in Neuropediatrics (ESMRN, www.esmrn.com)
member of the European Neonatal Brain Club (until 1-1-2012)
member of the Dutch Society of Pediatrics (NVK)
member of the Dutch Society of Perinatal Medicine
member of the Koninklijke Nederlandsche Maatschappij tot Bevordering der Geneeskunst
Scienfic achievements, scholarships, grants and prizes
He has been involved in many PhD studies, and has obtained grants from different sources. Publications cited in PubMed include more than 300 papers, and chapters in several text books of Neonatology.
Scholarships, grants and prizes include
– Ter Meulen Fonds, KNAW, Amsterdam 1993
– Sterproject Neurowetenschappen Universitair Medisch Centrum Utrecht 1995
– NWO AGIKO-stipendium 920-03-039
– Hersenstichting Nederland (Brain Foundation of the Netherlands) 10F02.07
– Dr.W.M.Phelps-Stichting voor Spastici 03.016
– Wilhelmina Kinderziekenhuis Onderzoekfonds 2003
– NWO ZonMW Doelmatigheidsonderzoek ‘Selection of preterm neonates at risk for neurodevelopmental disorders by segmentation of the brain using MRI’ 945-27-022
– Excellence in Academic Medicine, University Medical Center Utrecht 2009-2010.
– NWO ZonMW Priority Medicines For Children: Pharmacokinetics and Pharmacodynamics of Medication in Asphyxiated Newborns During Controlled Hypothermia.
PharmaCool National Multicenter Study. 40-41500-98-9002
– NWO ZonMW Adult mesenchymal stem cells (MSC) to regenerate the neonatal brain 40-41400-98-1103
Peter Reynolds (UK)View bio
Peter Reynolds is a Consultant Neonatologist at St. Peter’s Hospital in Surrey, UK. His main interests are focussed on improving outcomes through adopting a less-invasive, evidence-based approach to neonatal care, and to look for improvements in existing care to ensure optimal delivery and improved outcomes. His interests include the use of nasal High Flow in babies, with recent publications including clinical outcomes of babies receiving High Flow without CPAP and also the first clinical use of a new automatic oxygen controller. He works with leading companies in the medical devices industry such as Inspiration Healthcare to provide clinical leadership for product development in the neonatal world. He is currently part of a small UK expert group who will be publishing new consensus guidelines for the use of surfactant in RDS, and has also recently published work on improving the administration of surfactant via endotracheal fine catheter (LISA). He intends to have completed a study of a novel low-cost inflatable incubator and to be able to share these results with USANA attendees by the time of the meeting in 2019.
Click here to download the provisional programme.USANA PROGRAMME
CPD points will be applied for by Stellenbosch University.